Ching-Shiuann Yang

Title: **Ching-Shiuann Yang: Innovator in Tumor Imaging and Radiopharmaceuticals**

Introduction

Ching-Shiuann Yang is a distinguished inventor based in Hsinchu, Taiwan. With two patents to his name, Yang has made significant contributions to the field of medical imaging and cancer research. His innovative methods for developing radiopharmaceuticals hold promise for advancing diagnostic capabilities in oncology.

Latest Patents

Yang's recent patents include groundbreaking advancements in tracer methodologies for single photon emission computed tomography (SPECT). One notable invention details a method for preparing [I]Iodooctyl fenbufen amide, achieving a radiochemical yield of 15%, a specific activity of 37 GBq/μmol, and a radiochemical purity of 95%. This invention serves as a vital tracer to estimate the distribution of cyclooxygenase, allowing for the assessment of tumor development and metastasis through the binding characteristics of iodine isotope-labeled compounds.

Another significant patent is a tumor radiation probe employing an iodine-123 marker thymidine (FLT) analogue named [I]-IaraU. This innovative probe, synthesized from commercially available uridine, achieves a radiochemical purity exceeding 98% and specific activity not less than 0.196 GBq/μmol. The yield of this ingenious method can reach up to 40%, effectively reducing production costs while ensuring suitability for biological experiments.

Career Highlights

Ching-Shiuann Yang has worked with renowned institutions, including National Tsing Hua University and the Institute of Nuclear Energy Research, part of the Atomic Energy Council. These experiences have deepened his expertise in radiology and pharmaceutical applications, enabling him to make impactful contributions to the medical field.

Collaborations

Throughout his career, Yang has collaborated with highly skilled professionals, including fellow inventors Chung-Shan Yu and Ho-Lien Huang. Their joint efforts have surely enriched the innovative processes, fostering an environment that emphasizes teamwork and interdisciplinary approaches.

Conclusion

Ching-Shiuann Yang stands out as a pioneering inventor in the realms of tumor imaging and radiopharmaceutical development. His patents not only contribute to scientific advancement but also provide essential tools for clinicians in diagnosing and evaluating cancer. With continued collaboration and innovation, Yang's work will undoubtedly influence the future of medical diagnostics.